[Skip to content]

EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association
EPDA - European Parkinsons Disease Association
REWRITE TOMORROW
.

Research

Clinical trials

Various clinical trials are under way on a number of compounds in laboratory studies. Although many of the findings look promising there has been some controversy over the interpretation of results.  This is partly due to the considerable difficulty in both designing appropriate trials and finding precise clinical or instrumental markers to adequately measure results.

Over the next decade, it is hoped that there will be considerable advances in developing disease-modifying agents, running successful large scale clinical trials, and establishing effective methods to evaluate the neuroprotective benefits of compounds.


Important!

Neuroprotective research is very much in its infancy, so while new compounds are still being trialled and studied, deciding on which medications to take is very much a personal choice to be made with the guidance of a specialist doctor, taking into account individual needs and symptoms. 
EPDA EPDA EPDA EPDA EPDA EPDA EPDA EPDA